2026-11-10 · 2026-11 / week-2

WIX’s $250M AI Run Rate Meets a 16% Cash-Flow Guide, but the Short Is Not Bounded

WIX’s $250M AI Run Rate Meets a 16% Cash-Flow Guide, but the Short Is Not Bounded

Classification: Reject / no trade. This is a U.S.-listed short screen, not an order or a pending setup.

Summary: Wix’s Q3 revenue grew 13%, but bookings grew 11% and management cut its adjusted 2026 free-cash-flow-margin outlook to about 16%. Base44’s nearly $250 million ARR, improving retention and 58% Q3 non-GAAP gross margin are real counterevidence. At the last verified regular close, WIX was already near the low end of its estimated sales-multiple history; the reference-only short map has a flat base, a 16.2% squeeze stress and negative gross expected value.

Research timestamp: November 10, 2026, 17:10 Singapore time (09:10 UTC; 04:10 ET). The first post-result regular session had not opened. The latest usable regular close is November 9.

Opportunity Ranking

Rank Candidate Direction Mispricing Evidence Freshness Catalyst Window Positioning 10/5 Status Tradeability Main Rejection Risk
1 Wix (WIX) Short screen At the $69.75 pre-result close, bookings growth trailed revenue; 2026 adjusted FCF-margin outlook fell to ~16%, while Base44 ARR and retention improved. Refreshed market-cap/TTM-sales is about 1.33x. Fresh Q3 release; November 9 close predates it. First regular session after Q3; Q4 guide is current but no later exact reporting date was verified. FINRA-reported 6.17M shares short at Oct. 15 settlement; provider float percentages differ; borrow is unknown. Reject: flat base, >5% adverse stress, 1.01:1 gross reward/adverse, negative expected gross return. Low: no post-result regular quote, spread, depth, locate, borrow or exit-capacity evidence. Base44’s reported run rate, improving cohort retention and lower inference cost could convert into revenue and cash faster than the guide implies.
2 Sea Limited (SE) Short screen November 9 close $77.96, +2.94%; three businesses create different credit, commerce and gaming drivers. Q3 results were still pending at the cutoff. Q2 is the latest filed quarter; official Q3 schedule is fresh. Q3 release before the U.S. open; 7:30 a.m. ET call scheduled. Current short interest, borrow and flows were not verified. Not qualified: no post-result facts or completed scenario map. Low before the event; no current execution evidence. A new Q3 release could change credit growth, loss and cash evidence before the session.
3 On Holding (ONON) Short screen November 9 close $37.53, +0.46%. Premium growth and margin expectations leave a possible consumer-demand test, but Q2 showed strong DTC and Asia-Pacific growth. Q2 release is current primary evidence; Q3 scheduled for this morning. Q3 release before the U.S. open; 8:00 a.m. ET call scheduled. Current short interest, borrow and flows were not verified. Not qualified: results were not yet available. Low before the event; no current execution evidence. Constant-currency sales growth, DTC momentum and gross margin may persist.
4 SPDR S&P 500 ETF (SPY) Market control November 9 close $752.72, +2.37%. Broad-market reference, not a company-specific short thesis. November 9 close. None specific to this screen. Not used to infer positioning. N/A High relative liquidity does not create a short thesis. Broad-market strength can worsen a single-name squeeze.

Selected for this screen: WIX ranks first for information value, not as the best executable short. It has a new, quantified company report available before the first post-result regular session.

Why this one now: The report puts a measurable cash-conversion guide beside strong AI-product evidence. That tension can move the stock, but the observed price and valuation do not provide a favorable short payoff.

What should surprise the reader: Base44’s near-$250 million ARR is an issuer-reported annualized run rate, not $250 million of recognized revenue or cash. Yet Wix reports above-expectation retention in its oldest cohort, lower AI inference costs and 58% Q3 non-GAAP gross margin for Base44. The guide cut is mainly a decision to spend more on growth, not evidence that the product is failing.

Why WIX Ranks First for Information Value

The search compared three distinct mechanisms: Wix’s software bookings and AI cash-conversion bridge; Sea’s e-commerce, lending and gaming mix ahead of Q3; and On Holding’s premium-consumer demand, channel and margin test ahead of Q3. SPY was the broad-market control. Bitdeer’s AI-infrastructure/mining pivot was also checked, but its prior standalone screen and lack of a fresh Q3 release made it an archive comparator, not a new thesis.

The WIX archive contains one prior article, from July 2, about the completed tender, reduced share count and Q1 operating results. This screen uses Q3 bookings, Base44 cohort and margin disclosures, the lower FCF-margin outlook and the Q4 partner-softness guide. That new evidence changes the catalyst and risk boundary; it is not a refreshed version of the tender thesis. No WIX signal ID was found in the monthly signal archive.

Prior WIX Forecast Audit

The July 2 long note used a July 1 close of $48.88, a $72 top marker and a 1–3 month horizon. Its price path reached a $45.62 low on July 9, a 6.7% adverse move, then closed at $73.35 on October 1, up 50.1% from the reference and above the old top marker. But the August 4 Q2 release moved the full-year adjusted FCF-margin outlook to the high teens, crossing that note’s stated below-20% invalidation condition. The target path and fundamental invalidation both occurred; they are not exclusive forecast outcomes. Over the same window SPY rose 2.4%, from $745.76 to $763.99. This is a price-only audit, not an executed return. No position evidence exists, and overlapping target scenarios do not support a Brier score.

Why the First Regular Session Can Move More Than 5%

The November 9 WIX close fell 8.33% while SPY rose 2.37%. That relative move happened before the Q3 report and cannot be attributed to it. The report is new, the next regular session is the first session that can accept or reject its figures, and the company combines a lower cash-flow guide with unusually strong Base44 metrics. A move above or below 5% is plausible; direction and magnitude are not established.

WIX closed at $69.75 at 4:00 p.m. ET on November 9. StockAnalysis showed a $70.30 after-hours mark at 7:53 p.m. ET; ChartExchange showed $70.40 at 4:56 p.m. ET. Both observations preceded the Q3 release and conflict in value and time, so neither is a post-result price. A Yahoo search result displayed $73.90 at 12:45 a.m. ET, but the page returned an access error when opened and the print preceded the result. A StockAnalysis search crawl later displayed $74.01 without a clear observation time while its opened history page still showed the prior close and $70.30 mark. I exclude both unverified snippets. No reliable post-release premarket quote was verified by the research cutoff.

10/5 Asymmetry Gate

The map below uses the $69.75 November 9 regular close as a reference only. It is not a post-result entry. The historical-multiple low and recent high are stress markers, not fair value or a price ceiling.

  • Favorable top-case decline: 16.4%.
  • Highest-probability base-case decline: 0.0%, below the required 10%.
  • Credible adverse squeeze stress: 16.2%, beyond the allowed 5%; upside is not capped at the observed high.
  • Gross reward/adverse risk: 1.01:1, below 2:1.
  • Probability-weighted price-only short return: -1.6% before borrow, spread, slippage, fees and carrying costs.
  • Status: Reject / no trade. Missing post-result price acceptance and execution data block any entry independently.

What Should Surprise the Reader

The strongest bearish datapoint is not the Q3 GAAP loss. It is the combination of bookings growing more slowly than revenue, a further Q4 bookings lag expected from partner softness, and an adjusted FCF-margin guide reduced from the high teens to about 16%. The company also expects a roughly $10 million Q4 working-capital headwind from prepaying GPUs for future model use.

The strongest bullish datapoint is not just ARR. Wix says the earliest Base44 cohort’s 12-month renewal rates exceeded initial expectations, renewals improved across later cohorts, and Base44’s Q3 non-GAAP gross margin reached 58% from near zero in Q1. Management expects above-60% Base44 margin in Q4 and says most subscriptions are billed monthly, with ARR momentum expected to convert gradually into bookings and revenue. Those are issuer claims and forward expectations, but they directly challenge a short thesis that assumes AI growth is all cost and no cash.

The Setup

Wix released Q3 results before the U.S. open. Q3 revenue was $570.165 million, up 13% year over year; bookings were $573.003 million, up 11%; and total ARR reached $2.021 billion, up 15%. Partners revenue was $212.4 million, up 11%. Total non-GAAP gross margin was 69%, flat year over year and two percentage points higher sequentially. Base44 ARR was described by management as close to $250 million.

Q3 operating cash flow was $78.282 million and capital expenditures were $3.811 million, leaving issuer-defined FCF of $74.471 million versus $127.282 million in Q3 2025. Nine-month FCF was $202.086 million versus $417.388 million. Wix’s FCF measure excluding acquisition and restructuring costs was $99.637 million for Q3 and $273.065 million for nine months, compared with $159.410 million and $449.516 million a year earlier. The adjusted nine-month measure was therefore down about 39% year over year, while nine-month revenue grew about 14%.

These cash figures are not proof of a broken business. Wix attributes its lower full-year adjusted FCF-margin outlook primarily to accelerated Base44 marketing, plans to reinvest further gross-margin improvement in Q4, and expects near-term partner softness to affect bookings. The company maintained low-to-mid-teens full-year revenue growth and low-teens bookings growth. That is a lower cash-conversion path alongside a continuing growth plan.

The Market Price

The latest verified regular close is $69.75, down $6.34 or 8.33% on November 9, before the result. StockAnalysis/S&P Global reports regular-session volume of 1,554,624; ChartExchange reports a $69.72 close and 1,536,385 shares. The values are not averaged. Volume is not treated as evidence of institutional selling.

TGMCharts reports a $2.919 billion market capitalization using the November 9 price. Refreshed TTM revenue is a Desk calculation:

FY2025 revenue $1,993.044M + 9M2026 revenue $1,674.394M - 9M2025 revenue $1,468.775M = $2,198.663M.

At that market capitalization, the refreshed equity market-cap/TTM-sales ratio is 1.33x. TGM’s 1.37x display uses the November 9 price and revenue available before Q3; it estimates a five-year P/S range of 1.11x to 11.32x and a five-year average of 4.21x. Historical company multiples are approximate and share-count based. The current ratio is near the estimated low, not evidence that WIX is expensive. At 1.11x refreshed sales, the mechanical share-price sensitivity is $58.32: $69.75 × 1.11 / 1.3276. This is a low-confidence historical-multiple stress, not a fair-value target. P/S is an equity multiple, not enterprise value; Wix also reported $500.1 million of credit-facility loans and $1.130 billion of net convertible notes at September 30.

The Mispricing

The possible disagreement is between the market’s weak recent price action and the company’s continuing reported growth, against a cash guide that is now lower because Wix is choosing to reinvest in Base44. The November 9 relative underperformance is real; its cause is unknown, and it predates this report. A current, source-quality consensus set and post-release price are unavailable, so this screen does not claim that the market expected a specific bookings rate or had already priced the new FCF guide.

The short argument is that the company’s near-term cash conversion is weakening while its AI growth case depends on ARR turning into recognized revenue and bookings. The counterargument is strong: the product’s reported run rate, retention, gross-margin recovery and overall revenue growth may justify the investment, while a 1.33x sales multiple leaves less obvious valuation air to remove. Both can be true; the available evidence does not support a bounded short.

The Positioning

ChartExchange’s FINRA-sourced table showed 6,167,947 shares short as of October 15, equal to 15.45% of its stated 39,933,672-share float and 7.35 days to cover. MarketBeat reports the same raw short count but 11.28% of its float, showing why provider percentages should not be mixed. The October 15 settlement is stale for a report released November 10. The NYSE calendar schedules October 30 settlement data for November 10; the source page still displayed October 15 at this cutoff.

This is evidence of a meaningful reported short position, not evidence of current borrow availability, a squeeze, or today’s holder flows. Locate, borrow rate, recall terms, current short interest, options positioning, spread, depth, venue quality and exit capacity are unverified. FINRA distinguishes reported short interest from daily short-sale volume; neither establishes lendable supply.

The Catalyst

Step State at cutoff What to verify
Q3 results Released before the November 10 regular open. The report’s bookings, cash guide and Base44 metrics are available; first-session price acceptance is not.
First regular-session response Pending. Compare a completed regular close and volume with the November 9 reference. Do not treat an unverified premarket print as acceptance.
Q4 execution Forward-looking. Revenue is guided to low-double-digit growth; bookings growth is expected to continue lagging revenue because of partner softness. Reconcile partner bookings, Base44 billing mix, recognized revenue, FCF and the GPU prepayment. Exact next report date was not verified.
Short-interest update October 30 settlement scheduled for release November 10; the displayed page remained at October 15. Confirm the settlement date and raw shares; this still predates the Q3 release and is not borrow availability.

The cheapest falsification sequence for the bearish mechanism is the next reported bookings-by-segment table, Base44 revenue or collections evidence, the Q4 FCF bridge after marketing and GPU prepayment, and the next short-interest settlement. A falling price alone does not confirm deteriorating cash conversion.

The Payoff

The selected instrument for analysis is WIX common stock. No trade is proposed. There is no verified post-result entry or first-session acceptance, and no live locate, borrow cost, spread, depth or exit-liquidity check. Options are excluded because no verified live chain, spreads and maximum-loss analysis were completed.

The short map uses (i) the updated TTM-sales sensitivity at TGM’s estimated 1.11x historical low, (ii) the last regular close as the flat base, and (iii) WIX’s observed November 4 intraday high of $81.03 as an upside stress. The high is not a price ceiling; larger gaps remain possible. Scenario probabilities are subjective research weights, not observed frequencies or market-implied odds.

Price Target and Probability Map

Scenario Probability Target / Level Return / Payoff Horizon Conditions Evidence Quality
Top Case 20% $58.32 Short return +16.4% First regular-session close after Q3 A lower cash guide dominates the opening response and WIX revisits the estimated 1.11x historical sales-multiple low on refreshed TTM revenue. Low: estimated historical multiple, not fair value.
Base Case 50% $69.75 0.0% Same session Positive revenue and Base44 evidence offset the lower FCF guide; shares hold the pre-report close. Low: no post-result quote or consensus calibration.
Bottom Case 30% $81.03 Short return -16.2% Same session Base44 retention and margin evidence dominates; buyers squeeze the stock back to the observed November 4 high. Medium for the historical price; low as a ceiling or forecast.
Invalidation n/a No price stop is asserted. n/a Rebuild on new evidence Reported Base44 revenue and cash conversion improve while bookings and FCF guidance stabilize or rise; separately, any continued missing execution gate keeps entry blocked. Medium for the evidence test; no automatic action.

Probability-weighted expected value: (0.20 × $58.32) + (0.50 × $69.75) + (0.30 × $81.03) = $70.85; price-only expected short return is -1.6% before costs.

Current market level and timestamp: $69.75, November 9, 2026, 4:00 p.m. ET / 9:00 p.m. UTC, StockAnalysis/S&P Global. This is a pre-result regular close.

Primary instrument: WIX common stock. 10/5 favorable base move: 0.0%. 10/5 credible adverse move: +16.2% using a recent observed high as a stress, not a cap. 10/5 measurement basis: reference-only. 10/5 status: Reject. Confidence: Low.

The Kill Shot

The strongest counterparty case is that Wix is spending into a product whose run rate and retention are already visible: Base44 ARR is near $250 million, its oldest cohort renewed above initial expectations, Q3 gross margin reached 58%, and the company expects more than 60% in Q4. Total ARR grew 15%, revenue grew 13%, and the FCF guide reduction reflects accelerated sales and marketing investment. If customers renew and revenue catches the run rate, the current cash drag may be the cost of growth, not evidence of value destruction.

The load-bearing bearish assumption is that partner softness and Base44’s cash-conversion lag persist long enough to weaken the earnings and cash base before the product’s margins mature. That assumption is not established by one quarter. The same evidence that supports it also describes a management choice to reinvest and a product with improving unit economics.

The kill shot is the price map: even granting a 20% top-case probability, the 50% base is flat and the 30% bottom case is a 16.2% rise. The short fails before costs.

What Could Go Wrong

The $81.03 marker can be exceeded. A release-driven gap, stronger Base44 renewal or paid conversion, improved bookings, lower inference costs, analyst revisions or a broad software rally can lift WIX beyond the map. Short losses are theoretically unbounded. Halts, sparse premarket liquidity, borrow recalls, hard-to-borrow fees and unavailable exits can make realized losses exceed a close-to-close scenario. The November 9 drop and reported short interest do not protect a short seller.

The opposite error is to treat the 16% adjusted FCF-margin outlook as harmless. It may reveal a durable cost of acquiring AI customers, and company-defined FCF adjustments omit acquisition and restructuring costs. GAAP operating loss was $16.4 million in Q3 and stock-based compensation was $50.7 million. These facts justify monitoring the cash bridge; they do not create a favorable entry by themselves.

What Would Prove This Wrong

The short screen should be retired if filed results show Base44 revenue and collections converting the ARR run rate, bookings growth catching or exceeding revenue growth, Base44 gross margin improving as guided, and adjusted FCF margin stabilizing or rising without an offsetting increase in marketing or working-capital needs. Rebuild from those filings and a fresh regular-session price map; do not convert this record automatically.

A first-session price rise alone would not prove the operating case, just as a decline would not prove it. The cash and bookings bridge is the falsification test.

Risk Audit

Risk Treatment
Reference is pre-result No post-release quote or first regular-session acceptance was verified. Entry remains null.
Guide and metric definitions FCF margin excluding acquisition and restructuring costs is issuer-defined and non-GAAP. Keep it separate from reported FCF and GAAP operating loss.
ARR versus cash Base44 ARR and retention are issuer-reported; ARR is not recognized revenue, collections or FCF.
Historical-multiple model The 1.11x estimate comes from a third party and is a stress anchor, not fair value. TTM revenue is refreshed after Q3; share count and market-cap sources are not a current transfer-agent reconciliation.
Positioning Short interest is stale and float definitions conflict. Current borrow and beneficial ownership are unknown.
Instrument and exit No live quote, spread, depth, venue/volume quality, locate, fee, recall or exit-capacity evidence. No options, leverage or margin.
Gap and tail loss The recent $81.03 high is not a ceiling. A short can lose more through a gap, halt or squeeze.

Best Trade Strategy

No trade. Do not short WIX from the $69.75 reference. Do not use the $58.32 sensitivity as a price floor or the $81.03 high as a stop. Reopen the screen only after the first post-result regular close, current borrow and liquidity evidence, and a new scenario map show a base decline of at least 10%, an evidence-backed adverse case within 5%, a gross reward/adverse ratio of at least 2:1, and positive expected value after costs. If any required evidence remains absent, keep the short rejected.

Sources

  1. Wix Q3 2026 results and outlook, November 10, 2026 — issuer release, including bookings, revenue, cash flow, Base44, Q4 softness and revised FCF-margin outlook.
  2. Wix Q3 release copy and 1:00 a.m. ET release timestamp — secondary distribution metadata; issuer figures remain attributed to Wix.
  3. Wix Q2 2026 results, SEC Exhibit 99.1 — prior high-teens adjusted FCF-margin outlook and Q2 operating baseline.
  4. Wix 2025 Form 20-F — FY2025 revenue.
  5. WIX November 9 price history, StockAnalysis/S&P Global — regular close, OHLC and volume; page also displayed a pre-result 7:53 p.m. ET after-hours mark.
  6. WIX November 9 close and ChartExchange cross-check — differing close, volume and 4:56 p.m. ET after-hours observation; values are not averaged.
  7. WIX price-to-sales history, TGMCharts — November 9 market cap and estimated historical P/S range; historical estimates are approximate.
  8. WIX FINRA-sourced short interest, ChartExchange — October 15 settlement, raw shares and provider float.
  9. 2026 NYSE Group short-interest calendar — settlement and release schedule.
  10. FINRA: short interest, what it is and is not — distinction between short interest and daily short-sale volume.
  11. Sea Q3 2026 reporting schedule, Nasdaq/Business Wire and Sea investor relations — pending Q3 schedule and company page quote; the page showed $77.96 at 4:00 p.m. ET November 9 with a 15–20 minute delay.
  12. On Holding Q3 reporting schedule and Q3 call details — official premarket schedule and 8:00 a.m. ET call.
  13. On Holding Q2 2026 results — latest operating evidence available at the cutoff.
  14. ONON November 9 price history, StockAnalysis/S&P Global — regular-session reference.
  15. SPY November 9 historical close, ChartExchange — broad-market control; November 9 close and daily change.
  16. Prior WIX tender/Q1 article, July 2, 2026 — prior thesis boundary and forecast audit source.
  17. WIX July 1–October 1 price path, ChartExchange and SPY July 1–October 1 price path, ChartExchange — historical calibration marks only.
  18. Yahoo Finance WIX quote page — search-indexed $73.90 overnight print at 12:45 a.m. ET; the underlying page could not be opened and the observation predates the result, so it is excluded from the price map.

Research Quality Scorecard

Criterion Score Evidence and deduction
Market disagreement 3/5 Cash guide and bookings lag conflict with AI growth evidence, but market-implied expectations are not verified.
Evidence base 4/5 Fresh issuer release and filings; current post-result price and cash-conversion detail are missing.
Positioning and flows 2/5 October 15 short interest only; current flows, borrow and float are unknown or provider-dependent.
Catalyst path 4/5 Q3 is published and first-session acceptance is observable; next company-report date is not verified.
Payoff architecture 2/5 Scenarios are derived but reference-only, low-confidence and fail 10/5.
Invalidation discipline 4/5 Bookings, Base44 revenue conversion and FCF guide provide monitorable tests.
Differentiated insight 4/5 ARR has improved evidence, but monthly billing, bookings and cash conversion remain separate.
Client value 4/5 The no-trade conclusion identifies exactly which new data could change the screen.
Total 27/40 The score is a research-quality check, not a trade signal. Failed 10/5 takes precedence: Reject.

Bottom Line

Wix’s Q3 report makes the AI growth story more tangible and its cash cost more visible. The lower adjusted FCF-margin outlook and slower bookings deserve follow-up, but Base44’s reported retention and margin progress sit beside a low refreshed sales multiple. From the only verified regular-session reference, the short has a flat base, an adverse stress well above 5%, a 1.01:1 payoff ratio and negative expected gross value. Reject; no trade.

AI Illustration Prompt

Create a restrained editorial illustration of a small software studio at dawn: a precise ledger balancing two columns, “ARR” and “cash,” while a modest AI model runs quietly in the background; on the right, a clear window opens toward a public-market bell that has not rung. Use graphite, warm paper, muted cobalt and one restrained amber accent. No logos, tickers, numbers, charts, or implied trading instruction. Add a subtle, readable “The Mispricing Desk” watermark at lower right.